Riskpilot← Back to searchSign inGet full accessDoktor Marcus Bergman AB
ABActiveOrg 5590930763Orrspelsvägen 6General medical practice activities · NACE 8621Est. 20160 employees
Revenue 2025
SEK 138K
-56% vs 2024
EBITDA margin
68.4%
-66% vs 2024
Equity ratio
77.7%
Financial strength
Net profit 2025
SEK 57K
-74% vs 2024
| Revenue | SEK 138K | -56% |
| EBITDA | SEK 94K | -66% |
| Net profit | SEK 57K | -74% |
| Total assets | SEK 244K | -43% |
| Equity | SEK 190K | -44% |
| Employees | 0 | — |
Legal name
Doktor Marcus Bergman AB
Org number
5590930763
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
21 december 2016
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Föremålet för bolagets verksamhet ska vara att bedriva sjukvård, antingen i egen regi eller genom uthyrning av personal, och därmed förenlig verksamhet, samt att äga och förvalta fast och lös egendom.
Address
Orrspelsvägen 6
Email
msgbergman@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 267 | 272 | 408 | 312 | 138 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 243 | 245 | 385 | 274 | 94 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 243 | 245 | 385 | 274 | 94 |
| Net financials | — | −0 | 0 | 2 | 1 |
| Profit before tax | 243 | 245 | 385 | 276 | 72 |
| Tax | −52 | −51 | −79 | −57 | −15 |
| Net profit | 191 | 194 | 306 | 219 | 57 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 326 | 324 | 490 | 428 | 244 |
| Equity | 241 | 244 | 356 | 337 | 190 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 85 | 80 | 133 | 91 | 31 |
| Total debt | 85 | 80 | 133 | 91 | 31 |
EBITDA margin
68.4%
This company
15.8%
Market median
+333% vs market
20212025
Equity ratio
77.7%
This company
38.2%
Market median
+103% vs market
20212025
Return on equity
30.1%
This company
18.4%
Market median
+64% vs market
20212025
Net profit margin
41.4%
This company
8.1%
Market median
+411% vs market
20212025
Asset turnover
0.56×
This company
1.12×
Market median
-50% vs market
20212025
Debt / equity
0.29×
This company
0.62×
Market median
+53% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-09-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Doktor Marcus Bergman AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gösta Jonny Bergman | Deputy Board Member | 0 companies |
| Marcus Sven Gösta Bergman | Board of Directors | 0 companies |